Home / Health / Old Drug, New Hope for Type 1 Diabetes
Old Drug, New Hope for Type 1 Diabetes
30 Nov, 2025
Summary
- Metformin, a 100-year-old drug, may improve type 1 diabetes management.
- Australian trial shows metformin reduces insulin needs in type 1 patients.
- New research challenges previous beliefs about metformin's role.
A groundbreaking clinical trial conducted in Australia has revealed that metformin, a medication widely used for type 2 diabetes, can notably decrease insulin requirements for individuals living with type 1 diabetes. This finding offers a promising new approach to managing a condition that affects hundreds of thousands worldwide.
For years, doctors have anecdotally prescribed metformin to manage insulin resistance in type 1 diabetes. However, this new research, published in Nature Communications, indicates that metformin's benefit lies not in counteracting resistance, but in directly lowering the amount of insulin needed to maintain stable blood sugar levels.
These surprising results could revolutionize how type 1 diabetes is managed, potentially improving patient outcomes and reducing the daily challenges associated with intensive insulin therapy. The study underscores the evolving understanding of diabetes treatment and the potential of repurposing existing medications.
